Patents by Inventor Alister Campbell

Alister Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
    Patent number: 8536183
    Abstract: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Grant
    Filed: August 7, 2012
    Date of Patent: September 17, 2013
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Paul John Beswick, Alister Campbell, Andrew Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • Piperazine derivatives used as CAV2.2 calcium channel modulators
    Patent number: 8530478
    Abstract: The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: September 10, 2013
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Paul John Beswick, Alister Campbell, Andrew Peter Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • 3-PYRIDYLCARBONYL-PIPERAZINYLSULFONYL DERIVATIVES
    Publication number: 20120302746
    Abstract: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Application
    Filed: August 7, 2012
    Publication date: November 29, 2012
    Inventors: Paul John Beswick, Alister Campbell, Andrew Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
    Patent number: 8288388
    Abstract: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: October 16, 2012
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Paul John Beswick, Alister Campbell, Andrew Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • PIPERAZINE DERIVATIVES USED AS CAV2.2 CALCIUM CHANNEL MODULATORS
    Publication number: 20110130379
    Abstract: The present invention relates to novel piperazine derivatives (I); to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Application
    Filed: July 15, 2009
    Publication date: June 2, 2011
    Applicant: CONVERGENCE PHARMACEUTICALS LIMITED
    Inventors: Paul John Beswick, Alister Campbell, Andrew Peter Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases
    Publication number: 20110003862
    Abstract: Compounds of the formula (I), inhibit D-amino acid oxidase and hence find use in treating degenerative and psychiatric diseases.
    Type: Application
    Filed: February 15, 2007
    Publication date: January 6, 2011
    Applicants: MERCK SHARP & DOHME LIMITED, MERCK & CO., INC.
    Inventors: Philip E. Brandish, Nicholas Brandon, Alister Campbell, Timothy Sparey
  • Novel Derivatives
    Publication number: 20100022555
    Abstract: The present invention relates to novel piperazine derivatives; to processes for their preparation; to pharmaceutical compositions containing the derivatives; and to the use of the derivatives in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial.
    Type: Application
    Filed: July 15, 2009
    Publication date: January 28, 2010
    Inventors: Paul John Beswick, Alister Campbell, Andrew Cridland, Robert James Gleave, Jag Paul Heer, Neville Hubert Nicholson, Lee William Page, Sadie Vile
  • Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
    Publication number: 20090306169
    Abstract: The present invention provides the use of fused pyrrole carboxylic acids of formula (I) for the manufacture of a medicament to inhibit D-amino acid oxidase, particularly for the treatment of neurodegenerative and psychiatric disorders or diseases; certain compounds of formula I being novel, pharmaceutical compositions containing them, their use in medicine and methods of treatment using them are also disclosed.
    Type: Application
    Filed: October 5, 2006
    Publication date: December 10, 2009
    Inventors: Philip E. Brandish, Timothy Sparey, Alister Campbell, Andrew Pike, Nicholas Brandon, Wei Zheng
  • Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease
    Patent number: 7041688
    Abstract: Compounds of formula (I) are disclosed.
    Type: Grant
    Filed: April 24, 2003
    Date of Patent: May 9, 2006
    Assignee: Merck Sharp & Dohme Lt.d.
    Inventors: Alister Campbell, Mark Peter Ridgill
  • Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease
    Publication number: 20050215602
    Abstract: Compounds of formula (I) are disclosed. The compounds inhibit gamma-secretase and hence find use in treatment of Alzheimer's disease.
    Type: Application
    Filed: April 24, 2003
    Publication date: September 29, 2005
    Inventors: Alister Campbell, Mark Ridgill